SG Americas Securities’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-42,172
| Closed | -$3.59M | – | 3558 |
|
|
2020
Q3 | $3.59M | Buy |
42,172
+33,075
| +364% | +$1.67M | 0.02% | 469 |
|
|
2020
Q2 | $322K | Sell |
9,097
-34,603
| -79% | -$1.01M | ﹤0.01% | 2469 |
|
|
2020
Q1 | $589K | Buy |
43,700
+30,782
| +238% | +$518K | 0.01% | 1713 |
|
|
2019
Q4 | $273K | Buy |
12,918
+4,263
| +49% | +$75.2K | ﹤0.01% | 2263 |
|
|
2019
Q3 | $115K | Buy |
8,655
+1,319
| +18% | +$19.4K | ﹤0.01% | 2665 |
|
|
2019
Q2 | $102K | Sell |
7,336
-1,037
| -12% | -$15.6K | ﹤0.01% | 2808 |
|
|
2019
Q1 | $161K | Sell |
8,373
-14,265
| -63% | -$230K | ﹤0.01% | 2724 |
|
|
2018
Q4 | $323K | Buy |
+22,638
| New | +$449K | ﹤0.01% | 2129 |
|
|
2018
Q3 | – | Sell |
-7,171
| Closed | -$170K | – | 3588 |
|
|
2018
Q2 | $170K | Buy |
7,171
+289
| +4% | +$5.81K | ﹤0.01% | 2706 |
|
|
2018
Q1 | $101K | Sell |
6,882
-4,282
| -38% | -$70K | ﹤0.01% | 2968 |
|
|
2017
Q4 | $180K | Sell |
11,164
-15,186
| -58% | -$179K | ﹤0.01% | 2521 |
|
|
2017
Q3 | $368K | Buy |
26,350
+5,631
| +27% | +$56.1K | ﹤0.01% | 2076 |
|
|
2017
Q2 | $183K | Buy |
20,719
+10,323
| +99% | +$72.5K | ﹤0.01% | 2505 |
|
|
2017
Q1 | $67K | Sell |
10,396
-30,523
| -75% | -$155K | ﹤0.01% | 3071 |
|
|
2016
Q4 | $150K | Buy |
40,919
+28,744
| +236% | +$85K | ﹤0.01% | 2577 |
|
|
2016
Q3 | $40K | Buy |
+12,175
| New | +$34K | ﹤0.01% | 3202 |
|
|
2016
Q2 | – | Sell |
-28,315
| Closed | -$71K | – | 3139 |
|
|
2016
Q1 | $71K | Buy |
+28,315
| New | +$63.7K | ﹤0.01% | 2706 |
|
|
2015
Q2 | – | Sell |
-10,343
| Closed | -$40K | – | 2924 |
|
|
2015
Q1 | $40K | Sell |
10,343
-2,631
| -20% | -$11.4K | ﹤0.01% | 2389 |
|
|
2014
Q4 | $62K | Buy |
+12,974
| New | +$51.3K | ﹤0.01% | 2987 |
|
|
2013
Q4 | – | Sell |
-13,186
| Closed | -$82K | – | 3149 |
|
|
2013
Q3 | $82K | Buy |
+13,186
| New | +$75.9K | ﹤0.01% | 2708 |
|
SG Americas Securities's IMMU Position: Q4 2020 in Review
SG Americas Securities sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 42,172 shares — an estimated $3.59M sold.
SG Americas Securities first reported a position in IMMU in Q3 2013 and held it in 20 quarters. The position peaked at $3.59M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- SG Americas Securities reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- SG Americas Securities sold 42,172 Immunomedics Inc shares in Q4 2020, an estimated $3.59M.
- SG Americas Securities first reported a position in Immunomedics Inc in Q3 2013 and held it in 20 quarters.
- SG Americas Securities's Immunomedics Inc position peaked at $3.59M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on SG Americas Securities's 13F filing for Q4 2020, filed 4 Feb 2021.